Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational Insomnia

Overview of attention for article published in Neuropsychopharmacology, January 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs: 1 blog

wikipedia: 2 Wikipedia pages

Readers on

mendeley: 127 Mendeley

So far, Altmetric has seen 2 citations on 2 Wikipedia pages.

SB-649868

Cited by user Ptthnhan on 25 Aug 2019

SB-649,868

Cited by user Timetraveler3.14 on 25 Oct 2014

SB-649,868 is a dual orexin receptor antagonist in development by GlaxoSmithKline. The drug is currently in phase II development for insomnia.

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.